Table 6 Comparison between group I (control group) and group II (case group) regarding levels of hemoglobin, AST, ALT, albumin, total bilirubin, INR, platelets, and creatinine 12 weeks after treatment

Hemoglobin

Mean ± SD

12.36 ± 1.62

8.92 ± 1.63

10.021

0.001

Range

8.8–15.7

4.2–12.4

AST (U/L)

Normal

50 (100%)

40 (95.2%)

2.434

0.119

High

0 (0%)

2 (4.8%)

ALT (U/L)

Normal

50 (100%)

40 (95.2%)

2.434

0.119

High

0 (0%)

2 (4.8%)

Albumin (gm/dl)

Mean ± SD

4.25 ± 0.35

3.89 ± 0.41

4.682

0.001

Range

3.5–5.1

2.9–4.8

Bilirubin (mg/dl)

Mean ± SD

0.87 ± 0.43

0.70 ± 0.33

2.019

0.047

Range

0.3–2.6

0.1–1.9

INR

Mean ± SD

1.09 ± 0.08

1.08 ± 0.11

0.592

0.555

Range

1–1.26

0.88–1.36

Platelets (10³/mm³)

Mean ± SD

242.57 ± 69.99

233.35 ± 91.59

0.538

0.592

Range

155–501

114–570

Creatinine (mg/dl)

Median(IQR)

0.9 (0.8–1)

7 (5.87–8.9)

− 8.051

0.001

Range

0.6–1.2

3.6–12.8